Breaking News Instant updates and real-time market news.

SPNE

SeaSpine

$16.58

-0.54 (-3.15%)

16:47
10/19/18
10/19
16:47
10/19/18
16:47

First Light Asset Management reports 8.8% passive stake in SeaSpine

SPNE SeaSpine
$16.58

-0.54 (-3.15%)

10/16/18
PIPR
10/16/18
NO CHANGE
PIPR
Piper Jaffray discusses derivatives from J&J's Q3 results
Piper Jaffray analyst Matt O'Brien notes that Johnson & Johnson's (JNJ) global Medical Devices segment grew 1.7% organically in Q3, with sales of $6.6B falling $50M short of the consensus. The large joint segment continues to look relatively stable, with low-single-digit pricing pressures as expected, O'Brien tells investors in a research note. The analyst suspects Stryker (SYK) will continue to take share away from J&J and Zimmer Biomet (ZBH) in Q3. J&J's Spine segment was flat off of easy comps and after normalizing the Codman divestiture, the analyst adds. He continues to view J&J as a "share donor" to the pure-play spine names Globus Medical (GMED), NuVasive (NUVA) and SeaSpine (SPNE), with Globus' robot "continuing to provide share taking opportunities." Within Contact Lenses, J&J faced tough comps but reported a solid quarter in both the domestic and international markets, O'Brien says. He continues to see a "healthy" lens end market and one that is shifting to daily lenses from reusable, which he views as positive for Cooper Companies (COO). Further, the analyst notes that Diabetes continues to decelerate for J&J at a negative 20% clip given the Animas exit, which he thinks continues to be a positive for the pump names Insulet (PODD) and Tandem Diabetes (TNDM).
10/04/18
CANT
10/04/18
NO CHANGE
Target $22
CANT
Overweight
SeaSpine price target raised to $22 from $16 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for SeaSpine to $22 and reiterates an Overweight rating on the shares after hosting a chat with the company's CEO and CFO. The analyst now has more conviction that SeaSpine can consistently deliver growth in the high-single to low-double-digit range. He thinks the company is "finally starting to see the benefit of management's hard work over the last three years." Bijou views SeaSpine's 2018 sales guidance as conservative and sees upside to 2019 consensus estimates.
10/02/18
PIPR
10/02/18
NO CHANGE
Target $20
PIPR
Overweight
SeaSpine price target raised to $20 from $16 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for SeaSpine to $20 from $16 after the company pre-announced Q3 revenues that beat consensus, prompting management to increase its FY18 outlook. The momentum in the quarter was driven by strong market uptake of recently launched products generated by an increasingly exclusive and engaged distributor network, he notes, pointing out that this exemplifies management's execution of a turnaround strategy established three years ago post-spin by first increasing the mindshare of SeaSpine's products within its distributor network as well as attracting new distributor partners with a robust product suite. O'Brien reiterates an Overweight rating on the shares.
07/30/18
PIPR
07/30/18
NO CHANGE
Target $16
PIPR
Overweight
SeaSpine capturing market share, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien kept his Overweight rating and $16 price target on SeaSpine after its Q2 results. The analyst notes that the company's investments made over the past quarters are allowing it to capture spine market share and also grow above market rates. O'Brien adds that while SeaSpine trades at a "meaningful discount" relative to its peer group, that gap will be closed over time as the company extends its topline growth.

TODAY'S FREE FLY STORIES

UBSH

Union Bankshares

$34.56

-1.31 (-3.65%)

06:59
03/20/19
03/20
06:59
03/20/19
06:59
Initiation
Union Bankshares initiated  »

Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$10.63

-0.31 (-2.83%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Periodicals
Snapchat admits age verification process is effectively useless, BI reports »

Snap's senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

ZEAL

Zealand Pharma

$15.60

(0.00%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Hot Stocks
Breaking Hot Stocks news story on Zealand Pharma »

Zealand Pharma AS (ADS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Recommendations
Smartsheet analyst commentary  »

Smartsheet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

TXRH

Texas Roadhouse

$60.46

-0.39 (-0.64%)

06:56
03/20/19
03/20
06:56
03/20/19
06:56
Upgrade
Texas Roadhouse rating change  »

Texas Roadhouse upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, AZN

AstraZeneca

$42.87

0.29 (0.68%)

06:54
03/20/19
03/20
06:54
03/20/19
06:54
Recommendations
Bayer, AstraZeneca, Sanofi, Novartis, Merck analyst commentary  »

Bayer shares likely to…

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.87

0.29 (0.68%)

SNY

Sanofi

$45.18

0.27 (0.60%)

NVS

Novartis

$92.99

-0.205 (-0.22%)

MRK

Merck

$81.93

0.59 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 22

    Mar

  • 25

    Mar

  • 11

    Apr

  • 28

    Apr

  • 30

    Apr

  • 18

    May

  • 17

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Periodicals
Off-duty pilot saved Lion Air 737 day before fatal crash, Bloomberg reports »

An off-duty pilot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CTXS

Citrix

$101.31

-0.24 (-0.24%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Conference/Events
Citrix to host CEMEX Day 2019 »

CEMEX Day 2019 to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 17

    Apr

IRM

Iron Mountain

$34.51

-0.29 (-0.83%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Hot Stocks
Iron Mountain, MakeSpace announce partnership for storage services »

MakeSpace, an on-demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$175.77

6.86 (4.06%)

06:49
03/20/19
03/20
06:49
03/20/19
06:49
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$8.12

-0.07 (-0.85%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Initiation
Akebia initiated  »

Citi starts Akebia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMP

JMP Group

$3.79

-0.07 (-1.81%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Hot Stocks
JMP Group sells majority interest in JMP Credit Advisors »

JMP Group has sold a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$42.32

0.51 (1.22%)

06:47
03/20/19
03/20
06:47
03/20/19
06:47
Hot Stocks
Pfizer secures exclusive option to acquire Vivet Therapeutics »

Vivet Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 30

    Apr

  • 18

    May

FDX

FedEx

$181.50

-0.92 (-0.50%)

06:46
03/20/19
03/20
06:46
03/20/19
06:46
Recommendations
FedEx analyst commentary  »

FedEx remains 'story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

ENV

Envestnet

$66.69

0.29 (0.44%)

06:45
03/20/19
03/20
06:45
03/20/19
06:45
Downgrade
Envestnet rating change  »

Envestnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
03/20/19
03/20
06:45
03/20/19
06:45
General news
Breaking General news story  »

Week of 3/15 MBA Mortgage…

ZTS

Zoetis

$98.72

0.95 (0.97%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Initiation
Zoetis initiated  »

Zoetis resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$204.57

0.855 (0.42%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Conference/Events
Tyler Technologies management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

MO

Altria Group

$56.01

-1.295 (-2.26%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Periodicals
FDA commissioner calls meeting with Altria, Juul 'difficult', CNBC reports »

Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 16

    May

TDC

Teradata

$48.33

0.58 (1.21%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Downgrade
Teradata rating change  »

Citi downgrades Teradata…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

STL

Sterling Bancorp

$19.86

-0.39 (-1.93%)

06:40
03/20/19
03/20
06:40
03/20/19
06:40
Conference/Events
Sterling Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 18

    Jun

  • 19

    Jun

ELAN

Elanco

$33.00

1.36 (4.30%)

, ZTS

Zoetis

$98.72

0.95 (0.97%)

06:39
03/20/19
03/20
06:39
03/20/19
06:39
Initiation
Elanco, Zoetis initiated  »

Elanco resumed with a…

ELAN

Elanco

$33.00

1.36 (4.30%)

ZTS

Zoetis

$98.72

0.95 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

ROK

Rockwell Automation

$178.71

-2.02 (-1.12%)

06:38
03/20/19
03/20
06:38
03/20/19
06:38
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIBN

SI-Bone

$19.00

-0.01 (-0.05%)

06:37
03/20/19
03/20
06:37
03/20/19
06:37
Conference/Events
SI-Bone management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NOK

Nokia

$6.35

0.02 (0.32%)

06:36
03/20/19
03/20
06:36
03/20/19
06:36
Downgrade
Nokia rating change  »

Nokia downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.